Abstract
Specimen collection is an integral component of clinical research. Specimens from subjects with various stages of cancers or other conditions, as well as those without disease, are critical tools in the hunt for biomarkers, predictors, or tests that will detect serious diseases earlier or more readily than currently possible. Analytic methodologies evolve quickly. Access to high-quality specimens, collected and handled in standardized ways that minimize potential bias or confounding factors, is key to the "bench to bedside" aim of translational research. It is essential that standard operating procedures, "the how" of creating the repositories, be defined prospectively when designing clinical trials. Small differences in the processing or handling of a specimen can have dramatic effects in analytical reliability and reproducibility, especially when multiplex methods are used. A representative working group, Standard Operating Procedures Internal Working Group (SOPIWG), comprised of members from across Early Detection Research Network (EDRN) was formed to develop standard operating procedures (SOPs) for various types of specimens collected and managed for our biomarker discovery and validation work. This report presents our consensus on SOPs for the collection, processing, handling, and storage of serum and plasma for biomarker discovery and validation.
MeSH Terms
Biomarkers/blood
Blood Preservation
Blood Proteins/analysis
Clinical Trials as Topic
Humans
Light
Practice Guidelines as Topic
Proteomics/methods,standards,trends
Reproducibility of Results
Specimen Handling/methods,trends
Temperature
Chemicals
Biomarkers
Blood Proteins
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Tuck Melissa K
Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan 48109-0725, USA. mtuck@umich.edu
Chan Daniel W
Chia David
Godwin Andrew K
Grizzle William E
Krueger Karl E
Rom William
Sanda Martin
Sorbara Lynn
Stass Sanford
Wang Wendy
Brenner Dean E
References (10)
10 references, click to expand
-
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.
Clin Chem. 2008 Jan;54(1):44-52
PMID: 17981926
-
Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.
Clin Chem. 2007 Apr;53(4):645-56
PMID: 17303688
-
Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects.
Cancer Inform. 2005;1:98-104
PMID: 19305635
-
Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling.
Proteomics. 2006 May;6(10):3189-98
PMID: 16586434
-
Clinical proteomics: A need to define the field and to begin to set adequate standards.
Proteomics Clin Appl. 2007 Feb;1(2):148-56
PMID: 21136664
-
Effects of heparin on polymerase chain reaction for blood white cells.
J Clin Lab Anal. 1999;13(3):133-40
PMID: 10323479
-
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
Proteomics. 2005 Aug;5(13):3262-77
PMID: 16052621
-
the need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis.
Cancer Inform. 2005;1:86-97
PMID: 19305634
-
Assay interferences from blood collection tubes: a cautionary note.
Clin Chem. 2006 Aug;52(8):1627-8
PMID: 16873316
-
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.
J Clin Epidemiol. 2007 Dec;60(12):1205-19
PMID: 17998073